Cardxx (PK) (USOTC:CXCQ)
Historical Stock Chart
From Nov 2019 to Nov 2024
CardXX, Inc. (Pink Sheets: CXCQ) a leading provider of
advanced electronics packaging solutions including smart cards and
RFID devices today announced that it has received an initial test
purchase order for 2,000 SIRAD(TM) radiation dosimeter cards from New
Jersey-based JP Laboratories, Inc.
SIRAD(TM) is an abbreviation for Self-indicating, Instant
Radiation Alert Dosimeter. The SIRAD(TM) cards are user-friendly,
low-cost, wearable, and disposable radiation dosimeters for monitoring
high dosages of ionizing radiations. SIRAD cards are always active and
ready to use, enabling police officers, firefighters, and emergency
medical personnel to measure their radiation exposure while dealing
with the aftermath of a "dirty bomb" attack or nuclear explosion.
When asked about the purchase order, Phil Worack of CardXX
commented: "We're very pleased with this initial test order from JP
Laboratories, for SIRAD(TM) cards. Most importantly, both we and JP
Laboratories believe that SIRAD(TM) cards can be an important tool for
Homeland Security first responders in the combating of terrorism, and
dealing with the widespread effects of 'dirty bomb' attacks."
About CardXX
Colorado-based CardXX has developed patented technologies to
securely encapsulate electronics into smart cards and other portable
devices or form factors.
CardXX partnered with Spyrus to engineer the first smart card to
receive certification from the National Institute of Standards and
Technology (NSIT) for Overall Level 3 compliance, including Physical
Security with the Federal Information Processing Standard (FIPS) 140
-- Security Requirements for Cryptographic Modules.
The CardXX process offers the following unique advantages:
-- Injected thermoset polymer encapsulates and protects all
electronic elements completely and securely.
-- Low-temperature and low-pressure process prevents damage to
delicate electronics and improves manufacturing yield.
-- Superior heat resistance and chemical resistance protects
against physical and chemical attacks.
-- Physical access to chip electronics is difficult to obtain
without severe damage or destruction of chip.
About JP Laboratories
New Jersey-based JP Laboratories is a product research and
development firm that is active in the development of radiation
sensitive devices and products for combating terrorism, including the
companies SIRAD(TM). SIRAD's development was first funded by a SBIR
contract from the U.S. Naval Sea System Command and from past two
years by Technical Support Working Group (TSWG) with funds from the
U.S. Departments of Defense, Justice, Homeland Security and State.
The forward-looking statements contained herein are subject to
certain risks and uncertainties that could cause actual results to
differ materially from those reflected in the forward-looking
statements. Readers are cautioned not to place undue reliance on these
forward-looking statements, which reflect management's analysis only
as of the date hereof. The company undertakes no obligation to
publicly revise these forward-looking statements to reflect events or
circumstances that arise after the date thereof. Readers should
carefully review the risks described in other documents the company
files from time to time with the Securities and Exchange Commission,
including Quarterly Reports and Current Reports on Form 8-K.
SIRAD is a trade mark of JP Laboratories, Inc., U.S. Patent
5,420,000 and other patents pending.